Genome Editing Market (By Technology: Meganucleases, (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Others; By Delivery Method: Ex-vivo, In-vivo; By Mode: Contract, In-house; By End-use: Biotechnology and pharmaceutical companies, Academic and government research institutes, Contract research organizations; By Application: Genetic Engineering, Clinical Applications) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : May 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Genome Editing Market, By Technology

7.1.  Genome Editing Market, by Technology, 2020-2030

7.1.1.    (CRISPR)/Cas9

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    TALENs/MegaTALs

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    ZFN

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Genome Editing Market, By Delivery Method

8.1.  Genome Editing Market, by Delivery Method, 2020-2030

8.1.1.    Ex-Vivo

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    In-Vivo

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Genome Editing Market, By Application

9.1.  Genome Editing Market, by Application, 2020-2030

9.1.1.    Cell Line Engineering

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Animal Genetic Engineering

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Plant Genetic Engineering

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Other Applications

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Genome Editing Market, By End-use

10.1.        Genome Editing Market, by End-use, 2020-2030

10.1.1.  Biotechnology & Pharmaceutical Companies

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Academic & Government Research Institutes

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Contract Research Organizations

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Genome Editing Market, By Component

11.1.        Genome Editing Market, by Component, 2020-2030

11.1.1.  Contract

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  In-house

11.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Genome Editing  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Technology (2016-2030)

12.1.2.  Market Revenue and Forecast, by Delivery Method (2016-2030)

12.1.3.  Market Revenue and Forecast, by Application (2016-2030)

12.1.4.  Market Revenue and Forecast, by End-use (2016-2030)

12.1.5.  Market Revenue and Forecast, by Component (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.1.6.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.1.6.3.      Market Revenue and Forecast, by Application (2016-2030)

12.1.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.1.6.5.      Market Revenue and Forecast, by Component (2016-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.1.7.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.1.7.3.      Market Revenue and Forecast, by Application (2016-2030)

12.1.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.1.7.5.      Market Revenue and Forecast, by Component (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Technology (2016-2030)

12.2.2.  Market Revenue and Forecast, by Delivery Method (2016-2030)

12.2.3.  Market Revenue and Forecast, by Application (2016-2030)

12.2.4.  Market Revenue and Forecast, by End-use (2016-2030)

12.2.5.  Market Revenue and Forecast, by Component (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.2.6.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.2.6.3.      Market Revenue and Forecast, by Application (2016-2030)

12.2.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.2.6.5.      Market Revenue and Forecast, by Component (2016-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.2.7.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.2.7.3.      Market Revenue and Forecast, by Application (2016-2030)

12.2.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.2.7.5.      Market Revenue and Forecast, by Component (2016-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.2.8.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.2.8.3.      Market Revenue and Forecast, by Application (2016-2030)

12.2.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.2.8.5.      Market Revenue and Forecast, by Component (2016-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.2.9.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.2.9.3.      Market Revenue and Forecast, by Application (2016-2030)

12.2.9.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.2.9.5.      Market Revenue and Forecast, by Component (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Technology (2016-2030)

12.3.2.  Market Revenue and Forecast, by Delivery Method (2016-2030)

12.3.3.  Market Revenue and Forecast, by Application (2016-2030)

12.3.4.  Market Revenue and Forecast, by End-use (2016-2030)

12.3.5.  Market Revenue and Forecast, by Component (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.3.6.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.3.6.3.      Market Revenue and Forecast, by Application (2016-2030)

12.3.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.3.6.5.      Market Revenue and Forecast, by Component (2016-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.3.7.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.3.7.3.      Market Revenue and Forecast, by Application (2016-2030)

12.3.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.3.7.5.      Market Revenue and Forecast, by Component (2016-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.3.8.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.3.8.3.      Market Revenue and Forecast, by Application (2016-2030)

12.3.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.3.8.5.      Market Revenue and Forecast, by Component (2016-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.3.9.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.3.9.3.      Market Revenue and Forecast, by Application (2016-2030)

12.3.9.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.3.9.5.      Market Revenue and Forecast, by Component (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Technology (2016-2030)

12.4.2.  Market Revenue and Forecast, by Delivery Method (2016-2030)

12.4.3.  Market Revenue and Forecast, by Application (2016-2030)

12.4.4.  Market Revenue and Forecast, by End-use (2016-2030)

12.4.5.  Market Revenue and Forecast, by Component (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.4.6.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.4.6.3.      Market Revenue and Forecast, by Application (2016-2030)

12.4.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.4.6.5.      Market Revenue and Forecast, by Component (2016-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.4.7.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.4.7.3.      Market Revenue and Forecast, by Application (2016-2030)

12.4.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.4.7.5.      Market Revenue and Forecast, by Component (2016-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.4.8.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.4.8.3.      Market Revenue and Forecast, by Application (2016-2030)

12.4.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.4.8.5.      Market Revenue and Forecast, by Component (2016-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.4.9.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.4.9.3.      Market Revenue and Forecast, by Application (2016-2030)

12.4.9.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.4.9.5.      Market Revenue and Forecast, by Component (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Technology (2016-2030)

12.5.2.  Market Revenue and Forecast, by Delivery Method (2016-2030)

12.5.3.  Market Revenue and Forecast, by Application (2016-2030)

12.5.4.  Market Revenue and Forecast, by End-use (2016-2030)

12.5.5.  Market Revenue and Forecast, by Component (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.5.6.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.5.6.3.      Market Revenue and Forecast, by Application (2016-2030)

12.5.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.5.6.5.      Market Revenue and Forecast, by Component (2016-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

12.5.7.2.      Market Revenue and Forecast, by Delivery Method (2016-2030)

12.5.7.3.      Market Revenue and Forecast, by Application (2016-2030)

12.5.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

12.5.7.5.      Market Revenue and Forecast, by Component (2016-2030)

Chapter 13.  Company Profiles

13.1.              Caribou Biosciences, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Sangamo, Editas Medicine

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Recombinetics, Inc

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Thermo Fisher Scientific, Inc

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              CRISPR THERAPEUTICS

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Intellia Therapeutics

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Sigma Aldrich Corporation

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Healthcare Testing, Inspection, And Certification Outsourcing Market (By Services: Testing, Inspection, Certification; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...